Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 2,498.1 | 2,197.68 | 1,650.83 | 1,329.94 | 1,122.65 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,498.1 | 2,197.68 | 1,650.83 | 1,329.94 | 1,122.65 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 13.1 | 40.7 | 29.77 | 10.17 | 6.08 |
Total Income | 2,511.2 | 2,238.38 | 1,680.6 | 1,340.1 | 1,128.73 |
Total Expenditure | 1,858.1 | 1,593.67 | 1,135.04 | 959.05 | 877.65 |
PBIDT | 653.1 | 644.71 | 545.56 | 381.05 | 251.08 |
Interest | 47 | 30.55 | 16.03 | 32.5 | 39.94 |
PBDT | 606.1 | 614.17 | 529.53 | 348.55 | 211.14 |
Depreciation | 146.5 | 129.26 | 72.67 | 69.54 | 70.61 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 116.2 | 116.61 | 112.89 | 76.84 | 40.93 |
Deferred Tax | 7.4 | 2.48 | 0.17 | -3.3 | -15.48 |
Reported Profit After Tax | 336 | 365.81 | 343.8 | 205.48 | 115.07 |
Minority Interest After NP | 25.9 | 29.49 | 11.11 | 4.26 | 0 |
Net Profit after Minority Interest | 310.1 | 336.32 | 332.69 | 201.22 | 115.07 |
Extra-ordinary Items | 0 | 11.19 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 310.1 | 325.13 | 332.69 | 201.22 | 115.07 |
EPS (Unit Curr.) | 38.75 | 42.03 | 41.88 | 26.87 | 16 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 80 | 80.03 | 80.03 | 77.59 | 74.49 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 26.14 | 29.33 | 33.04 | 28.65 | 22.36 |
PBDTM(%) | 24.26 | 27.94 | 32.07 | 26.2 | 18.8 |
PATM(%) | 13.45 | 16.64 | 20.82 | 15.45 | 10.24 |
Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.
It has entered into a share purchase agreement to acquire a 100% equity stake in Chalasani Hospitals Pvt Ltd.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.